Onkure Therapeutics Inc (OKUR)

Finanzdaten der Onkure Therapeutics Inc-Aktie (OKUR)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	8.22%16.90	15.62	14.13	15.50	16.32
Research and Development	7.72%12.61	11.71	10.72	11.92	12.61
Operating Income/Loss	8.22%-16.90	-15.62	-14.13	-15.50	-16.32
Net Interest Income/Expense	239.08%1.55	0.46	0.62	0.80	0.93
	1.25%-15.35	-15.16	-13.50	-14.70	-15.39
Attributable To Parent	1.25%-15.35	-15.16	-13.50	-14.70	-15.39
Basic Average Shares	264.69%49.87	13.67	-	13.53	13.51
Diluted Average Shares	264.69%49.87	13.67	-	13.53	13.51
Basic Earnings Per Share	72.07%-0.31	-1.11	-	-1.09	-1.14
Diluted Earnings Per Share	72.07%-0.31	-1.11	-	-1.09	-1.14